Latest Form 144 filings
Officers, directors and other affiliates of a company file Form 144 when they place an order to sell restricted or control shares, if they plan to sell more than 5,000 shares or more than $50,000 worth within three months. It is a notice of a planned sale; officers and directors report the sale itself later on Form 4. 13D, 13G and Form 144 explained
Form 144 notices
Newest first. When a Form 144/A amends a notice, only the amendment is listed.
Filed in the last 365 days (US Eastern dates).
Form 144 filings on Livermore: Jan 4, 2023 to Oct 2, 2026.
Notices with a clearly misreported market value are left out of this list and its totals; they still appear, flagged, on the company's page. A value counts as misreported when the price per share it implies is far above the company's prices in Form 4 trades and 13F filings around the planned sale date.
- Notices
- 412
- Market value to sell
- $1.41B
- Sellers
- 117
- Companies
- 37
- Under 10b5-1 plans
- 219
| Company | Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|---|
| ADPTAdaptive Biotechnologies Corp | Mar 16, 20268:46 PM ET | Rubinstein JulieOfficer | 122.5K | $1.78M | Mar 11, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ADPTAdaptive Biotechnologies Corp | Mar 16, 20268:40 PM ET | Robins Harlan SOfficer | 470.3K | $6.83M | Mar 11, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ADPTAdaptive Biotechnologies Corp | Mar 16, 20268:33 PM ET | Robins Chad MOfficer ยท Director | 470.2K | $6.83M | Mar 11, 2026 | Morgan Stanley Smith Barney LLC | SEC |
| MPMP Materials Corp. | Mar 16, 20264:11 PM ET | Elliot HoopsOfficer | 13.9K | $835.0K | Mar 16, 202610b5-1 | Merrill | SEC |
| IOTSamsara Inc. | Mar 13, 20264:20 PM ET | Kirchhoff Benjamin LouisOfficer | 2.48K | $79.1K | Mar 13, 202610b5-1 | Charles Schwab & Co., Inc. | SEC |
| UHSUniversal Health Services Inc | Mar 13, 20264:06 PM ET | Elliot SussmanDirector | 356 | $68.8K | Mar 13, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| UHSUniversal Health Services Inc | Mar 11, 20264:55 PM ET | Elliot SussmanDirector | 318 | $59.3K | Mar 11, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ADPTAdaptive Biotechnologies Corp | Mar 11, 20264:42 PM ET | Francis LoOfficer | 30.6K | $444.2K | Mar 11, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ADPTAdaptive Biotechnologies Corp | Mar 11, 20264:21 PM ET | Michelle GriffinDirector | 15.4K | $214.1K | Mar 11, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ADPTAdaptive Biotechnologies Corp | Mar 10, 20267:53 PM ET | Lo FrancisOfficer | 38.1K | $625.9K | Mar 5, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| LPLALPL Financial Holdings Inc. | Mar 10, 202611:36 AM ET | Cohen Marc EliotOfficer | 1.09K | $337.0K | Mar 10, 2026 | Fidelity Brokerage Services LLC | SEC |
| LPLALPL Financial Holdings Inc. | Mar 9, 20264:13 PM ET | Cohen Marc EliotOfficer | 2.21K | $683.0K | Mar 9, 2026 | Fidelity Brokerage Services LLC | SEC |
| KRYSKrystal Biotech, Inc. | Mar 4, 20264:40 PM ET | Suma KrishnanDirector ยท Officer ยท 10% stockholder | 25.0K | $6.59M | Mar 4, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| KRYSKrystal Biotech, Inc. | Mar 4, 20264:39 PM ET | Krish KrishnanDirector ยท Officer ยท 10% stockholder | 25.0K | $6.59M | Mar 4, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ADPTAdaptive Biotechnologies Corp | Mar 3, 20264:59 PM ET | Harlan RobinsOfficer | 14.2K | $228.9K | Mar 3, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | Mar 3, 20264:59 PM ET | Chad RobinsOfficer | 53.1K | $853.6K | Mar 3, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | Mar 3, 20264:50 PM ET | Julie RubinsteinOfficer | 1.21M | $19.5M | Mar 3, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ADPTAdaptive Biotechnologies Corp | Mar 3, 20264:50 PM ET | Michelle GriffinDirector | 48.0K | $774.5K | Mar 3, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ASPIASP Isotopes Inc. | Mar 2, 20269:45 PM ET | Mann Paul ElliotDirector ยท Officer | 162.2K | $865.9K | Mar 2, 202610b5-1 | Independent Trading Group (ITG) Inc. | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Mar 2, 20266:48 PM ET | Masaru MatsudaOfficer | 12.1K | $313.9K | Mar 2, 202610b5-1 | Merrill Lynch | SEC |
| ATRAAtara Biotherapeutics, Inc. | Mar 2, 20266:25 PM ET | Nguyen AnhCoDirector ยท Officer | 3.35K | $18.2K | Mar 2, 2026 | Morgan Stanley Smith Barney LLC | SEC |
| ATRAAtara Biotherapeutics, Inc. | Mar 2, 20266:24 PM ET | Grant-Huerta YaninaOfficer | 2.35K | $12.8K | Mar 2, 2026 | Morgan Stanley Smith Barney LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Mar 2, 20266:22 PM ET | Larry Todd EdwardsOfficer | 3.69K | $92.8K | Mar 2, 2026 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Mar 2, 20266:22 PM ET | Todd WatanabeOfficer | 37.3K | $940.5K | Mar 2, 2026 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Mar 2, 20266:22 PM ET | Latha VairavanOfficer | 2.85K | $71.8K | Mar 2, 2026 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Mar 2, 20266:21 PM ET | Patrick BurnettOfficer | 6.29K | $158.3K | Mar 2, 2026 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Mar 2, 20265:59 PM ET | Keith LeonardBoard of Director | 39.3K | $997.2K | Mar 2, 202610b5-1 | Merrill | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Mar 2, 20265:25 PM ET | Howard WelgusDirector | 10.0K | $256.5K | Mar 2, 202610b5-1 | Merrill | SEC |
| ADPTAdaptive Biotechnologies Corp | Mar 2, 20265:24 PM ET | Harlan RobinsOfficer | 10.0K | $161.2K | Mar 2, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | Mar 2, 20265:24 PM ET | Chad RobinsOfficer | 289.0K | $4.66M | Mar 2, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| VIRVir Biotechnology, Inc. | Mar 2, 20264:35 PM ET | Vicki Lee SatoDirector | 88.0K | $799.9K | Mar 2, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| KRYSKrystal Biotech, Inc. | Mar 2, 202612:56 PM ET | Romano KathrynOfficer | 750 | $200.7K | Mar 2, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | Feb 27, 20264:47 PM ET | Chad RobinsOfficer | 182.9K | $2.93M | Feb 27, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| KRYSKrystal Biotech, Inc. | Feb 27, 20264:41 PM ET | Daniel S JanneyDirector | 11.8K | $3.25M | Feb 27, 202610b5-1 | Merrill Lynch | SEC |
| KRYSKrystal Biotech, Inc. | Feb 26, 20264:41 PM ET | Daniel S JanneyDirector | 7.74K | $2.13M | Feb 26, 202610b5-1 | Merrill Lynch | SEC |
| VIRVir Biotechnology, Inc. | Feb 25, 20269:00 PM ET | SVF Endurance (Cayman) LimitedShareholder | 400.0K | $3.80M | Feb 25, 2026 | Citigroup Global Markets Inc. | SEC |
| KRYSKrystal Biotech, Inc. | Feb 25, 20264:38 PM ET | Daniel S JanneyDirector | 700 | $192.5K | Feb 25, 202610b5-1 | Merrill Lynch | SEC |
| VIRVir Biotechnology, Inc. | Feb 25, 202610:48 AM ET | de Verneuil VaninaOfficer | 13.7K | $134.5K | Feb 25, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | Feb 25, 20269:48 AM ET | Eisner MarkOfficer | 1.89K | $18.5K | Feb 25, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| KRYSKrystal Biotech, Inc. | Feb 24, 20265:20 PM ET | Janney DanielDirector | 37.9K | $10.1M | Feb 24, 202610b5-1 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | Feb 24, 20265:16 PM ET | Eisner MarkOfficer | 1.62K | $15.4K | Feb 24, 2026 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | Feb 24, 20265:07 PM ET | De Backer MarianneOfficer ยท Director | 14.8K | $140.7K | Feb 24, 2026 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | Feb 24, 20264:57 PM ET | O'Byrne JasonOfficer | 1.63K | $15.6K | Feb 24, 2026 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | Feb 24, 20264:53 PM ET | Sabatini BrentOfficer | 1.43K | $13.6K | Feb 24, 2026 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | Feb 24, 20264:42 PM ET | de Verneuil VaninaOfficer | 3.12K | $29.7K | Feb 24, 2026 | Fidelity Brokerage Services LLC | SEC |
| KRYSKrystal Biotech, Inc. | Feb 24, 20264:39 PM ET | Daniel S JanneyDirector | 13.8K | $3.71M | Feb 24, 202610b5-1 | Merrill Lynch | SEC |
| VIRVir Biotechnology, Inc. | Feb 24, 20264:33 PM ET | Vicki Lee SatoDirector | 20.4K | $151.4K | Feb 24, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| FTHFaeth Therapeutics, Inc. | Feb 24, 20264:11 PM ET | Celebi JohnFormer officer | 3.37K | $116.4K | Feb 24, 2026 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | Feb 23, 20264:52 PM ET | O'Byrne JasonOfficer | 2.09K | $15.6K | Feb 23, 2026 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | Feb 23, 20264:34 PM ET | Eisner MarkOfficer | 2.09K | $15.6K | Feb 23, 2026 | Fidelity Brokerage Services LLC | SEC |